Yale study finds digital breast tomosynthesis cuts recall rates by 40 percent
Adding digital breast tomosynthesis to 2D mammography screening results in a 40 percent reduction in patient recall rates compared to routine screening mammography alone, a new study shows. The study, conducted at Yale University School of Medicine in New Haven, Conn., of 7,578 screening mammograms, found that the recall rate was 6.6 percent for digital breast tomosynthesis plus 2D screening mammography. It was 11.1 percent for 2D screening mammography alone.
Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.
This text may be reproduced or reused freely. Please credit the National Cancer Institute as the source. Any graphics may be owned by the artist or publisher who created them, and permission may be needed for their reuse.